Table 1.
Overall effect size calculation outcomes and the results from moderator analysis for growth performance (FCR and SGR), enzyme activity (SOD and LSA), disease resistance (CSR and GENE) and gut microbiota (MICRO).
| Growth performance | Subgroup | k | SMD (Hedges'g) | I2 | 95% CI | P-value | 95% PI |
|---|---|---|---|---|---|---|---|
| FCR | |||||||
| Overall | 77 | −0.70 | 95.75% | −1.22 to −0.18 | 0.0087 | −3.13 to 1.73 | |
| Dose-moderator | Low | 26 | −0.57 | −1.10 to −0.04 | 0.0363 | −3.01 to 1.87 | |
| Medium | 29 | −0.96 | −1.49 to −0.43 | 0.0004 | −3.40 to 1.48 | ||
| High | 22 | −0.55 | −1.08 to −0.01 | 0.0441 | −2.99 to 1.89 | ||
| Duration-moderator | 1 mo | 11 | −0.57 | −2.02 to 0.88 | 0.4402 | −3.46 to 2.32 | |
| 2 mo | 47 | −0.78 | −1.48 to −0.08 | 0.0287 | −3.37 to 1.81 | ||
| >2 mo | 19 | −0.57 | −1.69 to 0.56 | 0.3227 | −3.31 to 2.17 | ||
| IBW-moderator | Small | 41 | −0.61 | −1.34 to 0.12 | 0.0993 | −3.11 to 1.89 | |
| Medium | 22 | −0.39 | −1.37 to 0.60 | 0.4405 | −2.97 to 2.20 | ||
| Large | 14 | −1.41 | −2.61 to −0.21 | 0.0218 | −4.08 to 1.27 | ||
| SGR | |||||||
| Overall | 66 | 0.66 | 87.09% | 0.37 to 0.95 | <0.0001 | −0.59 to 1.91 | |
| Dose-moderator | Low | 24 | 0.55 | 0.25 to 0.85 | 0.0003 | −0.71 to 1.81 | |
| Medium | 23 | 0.97 | 0.67 to 1.27 | <0.0001 | −0.29 to 2.23 | ||
| High | 19 | 0.49 | 0.19 to 0.80 | 0.0014 | −0.77 to 1.76 | ||
| Duration-moderator | 2 mo | 52 | 0.60 | 0.27 to 0.93 | 0.0003 | −0.67 to 1.87 | |
| >2 mo | 14 | 0.89 | 0.26 to 1.52 | 0.0058 | −0.49 to 2.27 | ||
| IBW-moderator | Small | 36 | 0.48 | 0.08 to 0.87 | 0.0191 | −0.81 to 1.76 | |
| Medium | 14 | 0.77 | 0.15 to 1.40 | 0.0156 | −0.60 to 2.15 | ||
| Large | 16 | 0.93 | 0.38 to 1.49 | 0.0010 | −0.41 to 2.28 | ||
| Enzyme activities | |||||||
| SOD | |||||||
| Overall | 44 | 2.70 | 99.08% | 1.27 to 4.13 | 0.0002 | −3.00 to 8.39 | |
| Dose-moderator | Low | 15 | 2.39 | 0.94 to 3.85 | 0.0012 | −3.38 to 8.17 | |
| Medium | 16 | 3.11 | 1.66 to 4.57 | <0.0001 | −2.66 to 8.89 | ||
| High | 13 | 2.74 | 1.28 to 4.19 | 0.0002 | −3.04 to 8.51 | ||
| Duration-moderator | 1 mo | 13 | 5.19 | 3.17 to 7.20 | <0.0001 | 0.30 to 10.07 | |
| 2 mo | 19 | 1.78 | 0.09 to 3.46 | 0.0391 | −2.98 to 6.53 | ||
| >2 mo | 12 | 0.71 | −1.86 to 3.28 | 0.5889 | −4.43 to 5.84 | ||
| IBW-moderator | Small | 19 | 2.43 | 0.12 to 4.75 | 0.0396 | −3.68 to 8.55 | |
| Medium | 10 | 1.31 | −1.96 to 4.58 | 0.4328 | −5.23 to 7.84 | ||
| Large | 15 | 3.67 | 1.34 to 6.00 | 0.0020 | −2.44 to 9.79 | ||
| LSA | |||||||
| Overall | 62 | 2.11 | 97.51% | 1.34 to 2.88 | <0.0001 | −1.48 to 5.70 | |
| Dose-moderator | Low | 22 | 2.37 | 1.63 to 3.11 | <0.0001 | −1.03 to 5.77 | |
| Medium | 20 | 2.91 | 2.17 to 3.66 | <0.0001 | −0.49 to 6.32 | ||
| High | 20 | 1.17 | 0.43 to 1.91 | 0.0019 | −2.23 to 4.58 | ||
| Duration-moderator | 1 mo | 14 | 2.39 | 1.07 to 3.71 | 0.0004 | −1.05 to 5.83 | |
| 2 mo | 39 | 1.48 | 0.56 to 2.40 | 0.0017 | −1.83 to 4.79 | ||
| >2 mo | 9 | 4.08 | 2.22 to 5.93 | <0.0001 | 0.40 to 7.75 | ||
| IBW-moderator | Small | 23 | 2.65 | 1.37 to 3.93 | <0.0001 | −1.16 to 6.46 | |
| Medium | 10 | 1.72 | −0.36 to 3.80 | 0.1054 | −2.43 to 5.87 | ||
| Large | 29 | 1.80 | 0.65 to 2.94 | 0.0021 | −1.97 to 5.56 | ||
| Disease resistance | |||||||
| CSR | |||||||
| Overall | 49 | 0.73 | 99.94% | 0.44 to 1.01 | <0.0001 | −0.41 to 1.86 | |
| Dose-moderator | Low | 17 | 0.56 | 0.28 to 0.85 | <0.0001 | −0.56 to 1.69 | |
| Medium | 18 | 0.93 | 0.64 to 1.21 | <0.0001 | −0.20 to 2.05 | ||
| High | 14 | 0.71 | 0.43 to 0.99 | <0.0001 | −0.41 to 1.83 | ||
| Duration-moderator | 1 mo | 28 | 0.61 | 0.21 to 1.00 | 0.0026 | −0.57 to 1.79 | |
| 2 mo | 21 | 0.86 | 0.44 to 1.28 | <0.0001 | −0.33 to 2.05 | ||
| IBW-moderator | Small | 27 | 0.75 | 0.31 to 1.18 | 0.0008 | −0.49 to 1.98 | |
| Medium | 10 | 0.47 | −0.20 to 1.13 | 0.1700 | −0.87 to 1.80 | ||
| Large | 12 | 0.85 | 0.33 to 1.37 | 0.0013 | −0.41 to 2.12 | ||
| GENE | |||||||
| Overall | 378 | 2.70 | 99.42% | 0.09 to 5.48 | 0.0479 | −5.64 to 11.03 | |
| Gene-moderator | Caspase 3 | 22 | 3.59 | 0.78 to 6.41 | 0.0124 | −4.82 to 12.00 | |
| il | 133 | 2.76 | −0.06 to 5.57 | 0.0547 | −5.65 to 11.17 | ||
| mx | 23 | 2.99 | 0.18 to 5.81 | 0.0371 | −5.42 to 11.40 | ||
| stat | 40 | 2.11 | −0.70 to 4.92 | 0.1412 | −6.30 to 10.52 | ||
| tnf-α | 34 | 2.65 | −0.16 to 5.46 | 0.0650 | −5.76 to 11.06 | ||
| Other | 126 | 2.58 | −0.23 to 5.39 | 0.0721 | −5.83 to 10.99 | ||
| Tissue-moderator | Intestine | 142 | 5.72 | 1.92 to 9.51 | 0.0032 | −1.82 to 13.25 | |
| Kidney | 93 | 1.21 | −1.71 to 4.12 | 0.4173 | −5.92 to 8.33 | ||
| Liver | 46 | 1.10 | −1.82 to 4.01 | 0.4607 | −6.03 to 8.23 | ||
| Spleen | 97 | 0.12 | −2.80 to 3.03 | 0.9347 | −7.01 to 7.25 | ||
| Time-moderator | 0-h | 56 | 1.98 | −1.09 to 5.05 | 0.2060 | −7.20 to 11.16 | |
| 24-h | 239 | 3.35 | 0.28 to 6.42 | 0.0325 | −5.84 to 12.53 | ||
| 48-h | 83 | 2.96 | −0.11 to 6.03 | 0.0587 | −6.22 to 12.14 | ||
| Gut microbiota | |||||||
| MICRO | |||||||
| Overall | 29 | 0.09 | 57.52% | −0.24 to 0.41 | 0.6056 | −0.66 to 0.83 | |
| Structure-moderator | ACE | 6 | 1.01 | −0.60 to 2.63 | 0.2195 | −2.55 to 4.57 | |
| Shannon | 7 | 0.20 | −1.40 to 1.80 | 0.8091 | −3.36 to 3.75 | ||
| Simpson | 7 | 0.90 | −0.70 to 2.51 | 0.2696 | −2.65 to 4.46 | ||
| Chao 1 | 7 | 0.43 | −1.18 to 2.04 | 0.6014 | −3.13 to 3.99 | ||
| Observed-species | 2 | −0.53 | −2.19 to 1.14 | 0.5339 | −4.11 to 3.06 | ||
| Species-moderator | E. lanceolatus | 4 | 0.86 | −1.03 to 2.75 | 0.3749 | −1.79 to 3.50 | |
| P. yessoensis | 4 | −0.80 | −2.68 to 1.07 | 0.3996 | −3.43 to 1.82 | ||
| S. maximus | 16 | −0.74 | −2.59 to 1.11 | 0.4328 | −3.36 to 1.87 | ||
| L. crocea | 5 | 2.51 | 0.65 to 4.37 | 0.0083 | −0.11 to 5.13 | ||
k = the number of effect sizes; SMD = standardized mean difference; I2 = the heterogeneity index across studies; 95% CI = 95% confidence interval; 95% PI = 95% predicted interval; FCR = feed conversion ratio; SGR = specific growth rate; SOD = superoxide dismutase activity; LSA = lysozyme activity; IBW = initial body weight; CSR = cumulative survival rate after pathogen infection; GENE = expression of immune-related genes; MICRO = the abundance of gut microbiota; ACE = Abundance-based Coverage Estimator.